trihexyphenidyl has been researched along with Angina Pectoris, Variant in 1 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
Angina Pectoris, Variant: A clinical syndrome characterized by the development of CHEST PAIN at rest with concomitant transient ST segment elevation in the ELECTROCARDIOGRAM, but with preserved exercise capacity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joy, M | 1 |
| Haywood, GA | 1 |
| Webb-Peploe, MM | 1 |
1 other study available for trihexyphenidyl and Angina Pectoris, Variant
| Article | Year |
|---|---|
Management of a case of refractory variant angina with benzhexol hydrochloride (trihexyphenidyl hydrochloride).
Topics: Adult; Angina Pectoris, Variant; Electrocardiography; Female; Humans; Trihexyphenidyl | 1985 |